MedDataX Logo

Using the LINE@ Online Platform to Follow Up on Illegal Drug Use Among College and University Students

NCT ID: NCT07312591

Last Updated: 2025-12-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-01

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study developed a LINE@ online platform for tracking college and university students involved in illegal drug use, with the aim of evaluating the effectiveness of the intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Effectiveness indicators were collected using a structured questionnaire, including family functioning, severity of substance dependence, motivation for change, and emotional health management. In addition, a structured questionnaire was used to gather university students' user evaluations of the LINE@ online platform.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Illegal Drug Use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LINE@ Online Platform Intervention Group

LINE@ Online Platform Intervention

Group Type EXPERIMENTAL

LINE@ Online Platform Intervention

Intervention Type DEVICE

Using digital learning materials covering family functioning, substance dependence severity, motivation for change, and emotional health management.

Control Group

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LINE@ Online Platform Intervention

Using digital learning materials covering family functioning, substance dependence severity, motivation for change, and emotional health management.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* College students with a history of illegal drug use (confirmed by urine screening or other methods, such as self-reported use, curiosity-driven misuse, or accidental use)

Exclusion Criteria

* Younger than 18 years old
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Taiwan Normal University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Li Yi Xuan

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Taiwan Normal University

Taipei, Heping E. Rd, Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Li Li, BS

Role: CONTACT

Phone: 0912978806

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Guo Guo, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

202506HM023

Identifier Type: -

Identifier Source: org_study_id